Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions

Benjamin J Kim1, Dimitrios C Mastellos2, Yafeng Li1

  • 1Scheie Eye Institute, Department of Ophthalmology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Insights

Age-related macular degeneration (AMD) treatments are lacking for geographic atrophy. Targeting complement system proteins C3 and C5 shows promise for new AMD therapies, offering different inhibition strategies.

Area of Science:

  • Ophthalmology
  • Immunology
  • Biochemistry

Background:

  • Age-related macular degeneration (AMD) causes legal blindness, with geographic atrophy being a key unmet therapeutic need.
  • Complement cascade dysregulation is implicated in AMD pathogenesis.
  • C3 and C5 are central complement components and emerging therapeutic targets for AMD.

Purpose of the Study:

  • To provide a detailed review of C3 and C5 biology in AMD.
  • To critically assess therapeutic strategies targeting C3 and C5.
  • To explore connections between complement, inflammasome, and microglia/macrophage activity in AMD.

Main Methods:

  • Literature review and critical analysis of existing research on C3, C5, and AMD.
  • Discussion of biochemical and structural properties of C3 and C5.
  • Examination of therapeutic approaches targeting C3 and C5.

Main Results:

  • C3 and C5 play critical roles in AMD pathophysiology.
  • Therapeutics targeting C3 offer broad complement inhibition, while C5 inhibitors provide specificity.
  • Understanding C3/C5 interactions with inflammasomes and immune cells is crucial.

Conclusions:

  • Targeting C3 and C5 represents a promising avenue for AMD geographic atrophy treatment.
  • The choice between broad C3 inhibition and specific C5 inhibition requires further investigation.
  • Future research should focus on clarifying C3/C5 biology and its interplay with other inflammatory pathways in AMD.

Related Concept Videos

Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
6.8K
Anatomy of the Eyeball01:20

Anatomy of the Eyeball

The eye is a spherical, hollow structure composed of three tissue layers. The outer layer — the fibrous tunic, comprises the sclera — a white structure — and the cornea, which is transparent. The sclera encompasses some of the ocular surface, most of which is not visible. However, the 'white of the eye' is distinctively visible in humans compared to other species. The cornea, a clear covering at the front of the eye, enables light penetration. The eye's middle...
8.9K
The Retina01:32

The Retina

The retina is a layer of nervous tissue at the back of the eye that transduces light into neural signals. This process, called phototransduction, is carried out by rod and cone photoreceptor cells in the back of the retina.
73.5K
Photoreceptors and Visual Pathways01:22

Photoreceptors and Visual Pathways

At the molecular level, visual signals trigger transformations in photopigment molecules, resulting in changes in the photoreceptor cell's membrane potential. The photon's energy level is denoted by its wavelength, with each specific wavelength of visible light associated with a distinct color. The spectral range of visible light, classified as electromagnetic radiation, spans from 380 to 720 nm. Electromagnetic radiation wavelengths exceeding 720 nm fall under the infrared category,...
8.0K